Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
VIDEO: Understanding the relationship between rheumatoid arthritis, obesity
Healio spoke with Joshua Baker, MD, about the importance of early treatment of rheumatoid arthritis, the unmet needs of patients with rheumatoid arthritis, common comorbid conditions associated with rheumatoid arthritis and more.
VIDEO: Common comorbid conditions associated with rheumatoid arthritis
Healio spoke with Joshua Baker, MD, about the importance of early treatment of rheumatoid arthritis, the unmet needs of patients with rheumatoid arthritis, common comorbid conditions associated with rheumatoid arthritis and more.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Detecting early signs of rheumatoid arthritis
Healio spoke with Joshua Baker, MD, about the importance of early treatment of rheumatoid arthritis, the unmet needs of patients with rheumatoid arthritis, common comorbid conditions associated with rheumatoid arthritis and more.
VIDEO: Emerging therapies, recent developments in rheumatoid arthritis
Healio spoke with Joshua Baker, MD, about the importance of early treatment of rheumatoid arthritis, the unmet needs of patients with rheumatoid arthritis, common comorbid conditions associated with rheumatoid arthritis and more.
VIDEO: Addressing unmet needs in patients with rheumatoid arthritis
Healio spoke with Joshua Baker, MD, about the importance of early treatment of rheumatoid arthritis, the unmet needs of patients with rheumatoid arthritis, common comorbid conditions associated with rheumatoid arthritis and more.
Dementia risk lower in patients with rheumatoid arthritis treated with biologic DMARDs
Dementia risk decreases among patients with rheumatoid arthritis treated with biologic disease-modifying antirheumatic drugs, according to a systematic review and meta-analysis published in RMD Open.
FDA approves high-concentration, citrate-free form of interchangeable biosimilar Cyltezo
The FDA has approved a citrate-free, high-concentration formulation of the interchangeable adalimumab biosimilar Cyltezo to treat multiple chronic inflammatory diseases, according to the manufacturer.
Arthritis Awareness Month: Debunking myths, revealing truths
The month of May serves as Arthritis Awareness Month, drawing attention to this all-too common, yet misunderstood, condition.
Climate change linked with increases in autoimmune diseases
The effects of climate change break down epithelial barriers, enabling pollutants and other materials to penetrate the body and trigger or exacerbate autoimmune diseases, according to a review published in Frontiers in Science.
Proposed biosimilar shows equivalence to golimumab in rheumatoid arthritis
A biosimilar for golimumab has demonstrated therapeutic equivalence in rheumatoid arthritis, with no clinically meaningful safety differences, according to a press release from the manufacturer.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read